Details for 2012786739

Up to date per 28.05.2026

Actions

Title / Product Name

Verwendung von cxcr4-Antagonisten zur Behandlung von WHIM Syndrom, Myelokathexis, Neutropenia und Lymphozytopenia

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2012786739

EP Publication Number

2709991

E-Number

1307991

Language

PCT Number

US12037970

Publication Date

26.03.2014 A

02.09.2020 B1

Registration Date

02.09.2020

AT Publication Date

15.09.2020

Application Date

15.05.2012

Registration Number

Priorities

16.05.2011

201161486632 P

IPC

A61K 31/395 20060101AFI20191010BHEP

Maximum Duration of Protection

15.05.2032

Owner

Genzyme Corporation50 Binney Street Cambridge, MA 02142US

University of WashingtonCenter for Commercialization 4311 11th Avenue NE, Suite 500 Seattle, WA 98105US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

DALE, David, C.5302 Ne 42nd Street Seattle, WA 98105US

BRIDGER, Gary, J.445 South Garden Street Bellingham, WA 98225US

HSU, Frank, J.55 Cambridge Parkway Cambridge, MA 02142US